We had previously shown that Nutlin‐3a, another MDM2 inhibitor, has protective effects in postischemic acute kidney injury 12 and crescentic glomerulonephritis 13 via p53‐independent NFκB signal inhibition. This evidence concerns the gene MDM2 and crescentic glomerulonephritis.